Work

PS01.08: ABOUND.PS2 Interim Safety Results: nab -Paclitaxel/Carboplatin Followed by nab -Paclitaxel in NSCLC Patients with ECOG PS of 2

Year: 2016

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.09.044

Authors: Ajeet Gajra, Haythem Ali, Katayoun I. Amiri, Nagla A. Karim, Marc R. Matrana, Deborah Mulford, Teng J. Ong, Alexandra Sanford, Edgardo S. Santos, Mark A. Socinski, David R. Spigel

Institutions: SUNY Upstate Medical University, Henry Ford Health, Celgene (United States), University of Cincinnati, Ochsner Medical Center, University of Rochester Medicine, Florida Hospital Cancer Institute, Sarah Cannon

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2766333161

Cites:

Cited by:

Related to: 10